T1D patients are younger, more active and more prone to PA, which can enhance their insulin sensitivity, glycaemic control, lipid profile, antioxidant defences and renal function and also decrease blood pressure and cardiovascular diseases. This evidence concerns the gene INS and type 1 diabetes mellitus.